Aim
To provide individualised care for patients with cancer-related lymphoedema through the use of ICG lymphatic imaging to inform treatment planning.
Benefits
Increased patient centred care with targeted individualised therapy planning for chronic disease management. Increased patient engagement and confidence in their self management program.
*The clinic was placed on hold in March 2020 due to Covid-19 pandemic response.
Background
The lymphatic system functions as a drainage system of fluid as well as an immune system by controlling immune responses. It consists of lymphatics and lymph nodes (LNs), and plays important roles in the pathogenesis of several diseases, such as lymphedema, cancer metastasis, and various inflammatory conditions.
Cancer-related lymphoedema effects roughly one n seven people treated for cancer, with incidence estimates varying between 20-83% dependent on cancer type, treatments and diagnostic thresholds.
Lymphoedema is known to have a negative impact on a person’s quality of life, and has been reported as one of the most severe side effects of treatment for particular cancers.
Evidence also highlights that “lymphoedema is a major burden to any health care system because it is chronic, progressive, and requires lifelong treatment”.